USCAP Gynecologic Pathology Masterclass: Contemporary Issues in Light of Shifting Nomenclature, Criteria, and Ancillary Testing 2026 (Videos + Digital Slides)

Comprehensive Updates in Gynecologic Pathology, WHO Classification, Molecular Diagnostics, Biomarker Testing, and Precision Gynecologic Oncology

Stay current with the rapidly evolving field of gynecologic pathology through the USCAP Gynecologic Pathology Masterclass: Contemporary Issues in Light of Shifting Nomenclature, Criteria, and Ancillary Testing 2026, an advanced continuing medical education (CME) program developed by the United States and Canadian Academy of Pathology (USCAP). This comprehensive masterclass provides practicing pathologists and pathology trainees with an in-depth review of the latest diagnostic criteria, classification systems, molecular pathology advances, and biomarker testing that are transforming the diagnosis and management of gynecologic malignancies.

Released on July 1, 2026, this course is designed around the major updates introduced in the 6th Edition of the World Health Organization (WHO) Classification of Tumours of Female Reproductive Organs, together with revisions to FIGO staging, International Collaboration on Cancer Reporting (ICCR) recommendations, and the latest National Comprehensive Cancer Network (NCCN) clinical guidelines. Through expert-led lectures, challenging case discussions, and integrated digital whole-slide pathology, participants develop practical skills for applying modern diagnostic criteria, interpreting molecular findings, and incorporating biomarker testing into routine pathology practice.

A unique feature of this masterclass is the inclusion of digital whole-slide images (WSI) for every case. Participants can independently review unknown cases before each lecture or study the slides alongside faculty presentations, creating an interactive educational experience that closely simulates real-world diagnostic practice.

Product Details

• Course: USCAP Gynecologic Pathology Masterclass: Contemporary Issues in Light of Shifting Nomenclature, Criteria, and Ancillary Testing 2026
• Provider: United States and Canadian Academy of Pathology (USCAP)
• Original Release Date: July 1, 2026
• Format: Videos + Digital Whole Slide Images (WSI)
• Language: English
• Educational Level: Advanced

Course Overview

Gynecologic pathology continues to evolve rapidly as new molecular discoveries, updated classification systems, and precision oncology approaches reshape diagnostic pathology. The introduction of the WHO 6th Edition and revisions to international reporting standards require practicing pathologists to adopt new terminology, recognize newly defined disease entities, and incorporate ancillary testing into everyday diagnostic workflows.

This comprehensive masterclass reviews the most significant updates affecting tumors of the female reproductive tract, including ovarian, endometrial, cervical, vulvar, vaginal, mesenchymal, gestational, and sex cord-stromal neoplasms. Faculty members explain how evolving histopathologic criteria, molecular diagnostics, biomarker assessment, and standardized reporting influence diagnosis, staging, prognosis, and therapeutic decision-making.

Participants also gain practical experience through interactive digital pathology cases that reinforce pattern recognition, differential diagnosis, and evidence-based interpretation of complex gynecologic lesions.

What You’ll Learn

After completing this course, participants will be able to:

• Apply the updated WHO 6th Edition classification of female reproductive tract tumors.
• Incorporate current FIGO staging systems into diagnostic pathology reporting.
• Utilize ICCR reporting recommendations and NCCN clinical guidelines in daily practice.
• Recognize newly classified gynecologic neoplasms and evolving diagnostic terminology.
• Determine when molecular testing is required for accurate diagnosis.
• Interpret biomarker testing for ovarian, endometrial, and cervical cancers.
• Apply precision pathology principles to risk stratification and therapeutic decision-making.
• Improve diagnostic confidence through interactive whole-slide pathology review.

Comprehensive Topics Covered

WHO Classification of Female Reproductive Tumors

Review the latest updates introduced in the 6th Edition of the World Health Organization Classification of Tumours of Female Reproductive Organs, including revised terminology, newly recognized entities, updated diagnostic criteria, and contemporary disease classification.

FIGO, ICCR & NCCN Updates

Gain practical guidance on applying current international standards for gynecologic cancer diagnosis, staging, pathology reporting, and multidisciplinary patient management.

Topics include:

• FIGO staging revisions
• ICCR reporting standards
• NCCN guideline updates
• Standardized pathology reporting
• Evidence-based clinical recommendations

Endometrial Pathology

Develop expertise in diagnosing endometrial hyperplasia, carcinoma, precursor lesions, and molecular subtypes while integrating modern classification systems and biomarker assessment.

Ovarian Pathology

Review contemporary diagnostic approaches to epithelial ovarian tumors, borderline tumors, germ cell tumors, and sex cord-stromal neoplasms, with emphasis on molecular profiling and targeted therapies.

Cervical & Lower Genital Tract Pathology

Explore current classification systems and nomenclature for cervical, vulvar, and vaginal neoplasia, including HPV-associated lesions, precursor abnormalities, and invasive malignancies.

Mesenchymal & Non-Epithelial Gynecologic Tumors

Gain practical insight into the diagnosis of:

• Mesenchymal tumors
• Uterine sarcomas
• Sex cord-stromal tumors
• Gestational trophoblastic disease
• Rare gynecologic neoplasms

Faculty explain when molecular testing is essential for establishing a definitive diagnosis according to current WHO criteria.

Molecular Pathology

Learn how modern molecular diagnostics are transforming gynecologic pathology.

Topics include:

• Molecular classification
• Next-generation molecular testing
• Genomic alterations
• Precision pathology
• Molecular biomarkers
• Targeted therapies

Participants review situations in which molecular testing directly influences diagnosis, prognosis, and treatment selection.

Biomarker Testing

Develop confidence in interpreting clinically relevant biomarkers for gynecologic malignancies.

Topics include:

• Ovarian cancer biomarkers
• Endometrial cancer biomarkers
• Cervical cancer biomarkers
• Predictive biomarkers
• Prognostic biomarkers
• Companion diagnostics

Faculty discuss the expanding role of biomarker testing in personalized cancer therapy.

Digital Pathology & Whole Slide Imaging

A distinctive component of this masterclass is the interactive digital pathology experience.

Participants can:

• Review unknown cases before lectures
• Study high-resolution whole-slide images (WSI)
• Compare interpretations with expert faculty
• Strengthen microscopic diagnostic skills
• Improve pattern recognition

This practical approach closely simulates routine diagnostic sign-out and board examination preparation.

Learning Objectives

Upon completion of this educational activity, participants will be able to:

• Apply current WHO classification updates to tumors of the female reproductive tract.
• Utilize updated FIGO staging systems, ICCR reporting recommendations, and NCCN guidelines.
• Recognize newly classified gynecologic neoplasms and evolving diagnostic terminology.
• Determine when molecular testing is required for non-epithelial gynecologic neoplasms.
• Interpret biomarker testing for ovarian, cervical, and endometrial cancers.
• Integrate molecular pathology and precision medicine into routine diagnostic practice.
• Improve diagnostic accuracy through digital slide interpretation and case-based learning.

Educational Highlights

• WHO 6th Edition Classification
• Gynecologic Pathology
• Ovarian Pathology
• Endometrial Pathology
• Cervical Pathology
• Vulvar & Vaginal Pathology
• FIGO Staging
• ICCR Reporting Standards
• NCCN Guidelines
• Molecular Pathology
• Biomarker Testing
• Precision Oncology
• Whole Slide Imaging (WSI)
• Digital Pathology
• Mesenchymal Tumors
• Sex Cord-Stromal Tumors
• Gestational Trophoblastic Disease
• Case-Based Learning
• Interactive Digital Slides
• Continuing Medical Education (CME)

Why This Course Stands Out

The USCAP Gynecologic Pathology Masterclass 2026 provides one of the most comprehensive educational reviews available on contemporary gynecologic pathology. Rather than focusing solely on morphology, the course integrates updated WHO classification systems, international reporting standards, molecular diagnostics, biomarker interpretation, and precision oncology into a practical, case-based curriculum. The inclusion of interactive whole-slide digital pathology allows participants to strengthen diagnostic skills through realistic microscopic case review, making this masterclass particularly valuable for both daily practice and board preparation.

Target Audience

This educational activity is ideal for:

• Academic Pathologists
• Community Pathologists
• Surgical Pathologists
• Gynecologic Pathologists
• Molecular Pathologists
• Cytopathologists
• Pathology Residents
• Pathology Fellows
• Medical Oncologists
• Gynecologic Oncologists
• Physicians interested in gynecologic oncology and diagnostic pathology

Why Choose This Course?

Whether you practice academic pathology, community surgical pathology, or are preparing for board examinations, the USCAP Gynecologic Pathology Masterclass: Contemporary Issues in Light of Shifting Nomenclature, Criteria, and Ancillary Testing 2026 delivers an exceptional evidence-based review of modern gynecologic pathology. Combining internationally recognized faculty, updated WHO classifications, molecular diagnostics, biomarker interpretation, interactive whole-slide imaging, and practical case discussions, this program equips pathologists with the knowledge and confidence needed to provide accurate diagnoses and support precision oncology.

+ Topics:

• Pathology of Ovarian Epithelial Tumors – C. Blake Gilks, MD

• Molecular Testing in Ovarian Cancer – Ian S. Hagemann, MD, PhD

• Endometrial Pathology – Charles “Matt” Quick, MD

• Molecular Testing in Endometrial Cancer – Ian S. Hagemann, MD, PhD

• Endometrium – Charles “Matt” Quick, MD

• Molecular Testing in Mesenchymal and Gestational Trophoblastic Lesions – Ian S. Hagemann, MD, PhD

• Biomarker Testing in Lower Genital Tract Neoplasia – Ian S. Hagemann, MD, PhD

• Ovarian Epithelial Lesions – C. Blake Gilks, MD

• Ovarian Non-Epithelial Lesions – Marisa R. Nucci, MD

• Pathology of Non-Epithelial Ovarian Tumors – Marisa R. Nucci, MD

• Gynecologic Mesenchymal Neoplasia – Brooke E. Howitt, MD

• Mesenchymal Neoplasms – Brooke E. Howitt, MD

• Cervix – Carlos Parra-Herran, MD

• Pathology of the Uterine Cervix – Carlos Parra-Herran, MD

• Vulvo-Vaginal Pathology – Marilyn A. Kinloch, MD, FRCPC

• Vulva – Marilyn A. Kinloch, MD, FRCPC

• Roundtable: Grey Areas in Endometrial Pathology

• Roundtable: Grey Areas in Ovarian Pathology

• Roundtable: Grey Areas in Non-Epithelial Gynecologic Neoplasia

• Roundtable: Grey Areas in Lower Genital Tract Pathology